Safety Alerts & Recalls

What does this mean?

The FDA has told healthcare professionals to continue to follow the recommendations found in the prescribing information for Actos. If you take Actos or one of the combination products, do not stop taking your medicine unless told to do so by your healthcare professional. If you have concerns about your medicine, please talk to your doctor or other healthcare professional.

If you experience any side effects from your medicines, you can report them to the FDA MedWatch program by phone at 1-800-332-1088; by fax at 1-800-332-0178; by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787; or on the MedWatch website at

FDA Announces Safety Review of Actos (Pioglitazone) for Cancer Risk

The U.S. Food and Drug Administration (FDA) is conducting a review of results from an ongoing, ten-year study designed to determine if Actos (pioglitazone) is associated with an increased risk of bladder cancer. Findings from studies in animals and humans suggest this potential safety risk needs further study. The FDA has not concluded that Actos increases the risk of bladder cancer. The FDA's review of this safety concern is ongoing and the FDA will update the public when more information is available.

Actos contains the active ingredient pioglitazone and is used in the treatment of type 2 diabetes. Pioglitazone is also sold in combination with other diabetes medicines under the brand names Duetact, Actosplus Met, and Actosplus Met XR.

For more information, please visit: more information here

Source: FDA
Publication Date: 2010-09-17
Last Updated: 2010-09-18

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.